+Search query
-Structure paper
| Title | NSD2 Degradation Remediates the Oncogenic Cistrome in t(4;14) Multiple Myeloma. |
|---|---|
| Journal, issue, pages | Blood, Year 2026 |
| Publish date | Jun 29, 2026 |
Authors | Bo Hu / Jacob Edwards / Hardik Modi / Jim Gamez / Oscar Enrique Echeagaray / Kyle Hess / Yue Ren / Diana Anderson / Marta Larrayoz / Jinyi Zhu / Scott Arne Johnson / Gauri Deb / Diana Jankeel / Preethi Janardhanan / Jim Leisten / Sophie Peng / Andy Christoforou / Nicholas Stong / Celia Fontanillo / Chad C Bjorklund / Patrick Ryan Hagner / Anita Krithivas Gandhi / Jose A Martínez-Climent / Rama Krishna Narla / Antonia Lopez-Girona / Mark Rolfe / Neil Bence / Deborah S Mortensen / Lynda Groocock / ![]() |
| PubMed Abstract | The t(4;14) chromosomal translocation drives overexpression of the histone methyltransferase NSD2 and defines a high-risk segment of multiple myeloma (MM) patients. Herein, we report the discovery of ...The t(4;14) chromosomal translocation drives overexpression of the histone methyltransferase NSD2 and defines a high-risk segment of multiple myeloma (MM) patients. Herein, we report the discovery of NSD2-LDD, a cereblon-recruiting and PWWP1-mediated ligand directed degrader (LDD) that selectively and potently eliminates full length and PWWP1 domain containing NSD2 protein isoforms. NSD2-LDD treatment induces global loss of H3K36me2 leading to promoter-proximal spreading of H3K27me3 and re-wiring of cis-regulatory interactions that reverse t(4;14) transcriptional programs. These effects suppress MM disease-associated phenotypes including stromal adhesion, three-dimensional colony growth and paracrine signaling. By integrating patient single cell profiles with model 3D epigenomic and spatial transcriptomics, we delineate t(4;14) disease state together with the tumor-intrinsic reprogramming and resultant remodeling of the bone marrow microenvironment upon NSD2 degradation. In cell line derived xenografts and genetically engineered mouse models of t(4;14), NSD2-LDD extends median survival accompanied by tumoral H3K36me2 loss and niche re-modelling. Although the NSD2-LDD response is restricted to PWWP1-containining models, collectively this work validates NSD2 as a tractable dependency and supports clinical development of NSD2 degradation as a novel, targeted therapeutic strategy in high-risk MM. |
External links | Blood / PubMed:42371798 |
| Methods | EM (single particle) / X-ray diffraction |
| Resolution | 2.023 - 3.1 Å |
| Structure data | EMDB-72526, PDB-9y61: ![]() PDB-9y60: |
| Chemicals | ![]() PDB-1csp: ![]() ChemComp-HOH: ![]() PDB-1csq: ![]() ChemComp-ZN: |
| Source |
|
Keywords | TRANSFERASE / NSD2 / PWWP1 / binder / methyltransferase / LIGASE / Cereblon / degrader / DDB1 / LDD |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors

External links






homo sapiens (human)
Keywords